<VariationArchive RecordType="classified" VariationID="11482" VariationName="NG_008292.2:g.(?_707879)_(1040749_?)del" VariationType="Deletion" Accession="VCV000011482" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-26" DateCreated="2021-08-07" MostRecentSubmission="2021-08-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26521" VariationID="11482">
      <GeneList>
        <Gene Symbol="IL1RAPL1" FullName="interleukin 1 receptor accessory protein like 1" GeneID="11141" HGNC_ID="HGNC:5996" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xp21.3-21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="28587446" stop="29956718" display_start="28587446" display_stop="29956718" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="28605680" stop="29974016" display_start="28605680" display_stop="29974016" Strand="+" />
          </Location>
          <OMIM>300206</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IL1RAPL1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IL1RAPL1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NG_008292.2:g.(?_707879)_(1040749_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.1-p21.3</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>EX2-5DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008292.2" sequenceAccession="NG_008292" sequenceVersion="2" change="g.(?_707879)_(1040749_?)del">
            <Expression>NG_008292.2:g.(?_707879)_(1040749_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300206.0003" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_008292.2:g.(?_707879)_(1040749_?)del AND Intellectual disability, X-linked 21" Accession="RCV000012237" Version="13">
        <ClassifiedConditionList TraitSetID="3136">
          <ClassifiedCondition DB="MedGen" ID="C5551510">Intellectual disability, X-linked 21</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-08-07" MostRecentSubmission="2021-08-07">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21484992</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19012350</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3136" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5490" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mental retardation, X-linked 21/34</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation 21, X-linked</ElementValue>
                <XRef ID="X-linked+mental+retardation+21/9497" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, X-linked 21</ElementValue>
                <XRef ID="MONDO:0010256" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 34</ElementValue>
                <XRef Type="MIM" ID="300143" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 21</ElementValue>
                <XRef Type="MIM" ID="300143" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300206.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300206.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300206.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300206.0003" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XLID21</ElementValue>
                <XRef Type="MIM" ID="300143" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX34</ElementValue>
                <XRef Type="MIM" ID="300143" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">NR0B1-related adrenal hypoplasia congenita includes both X-linked adrenal hypoplasia congenita (X-linked AHC) and Xp21 deletion (previously called complex glycerol kinase deficiency). X-linked AHC is characterized by primary adrenal insufficiency and/or hypogonadotropic hypogonadism (HH). Adrenal insufficiency is acute infantile onset (average age 3 weeks) in approximately 60% of affected males and childhood onset (ages 1-9 years) in approximately 40%. HH typically manifests in a male with adrenal insufficiency as delayed puberty (i.e., onset age &gt;14 years) and less commonly as arrested puberty at about Tanner Stage 3. Rarely, X-linked AHC manifests initially in early adulthood as delayed-onset adrenal insufficiency, partial HH, and/or infertility. Heterozygous females very occasionally have manifestations of adrenal insufficiency or hypogonadotropic hypogonadism. Xp21 deletion includes deletion of NR0B1 (causing X-linked AHC) and GK (causing glycerol kinase deficiency), and in some cases deletion of DMD (causing Duchenne muscular dystrophy). Developmental delay has been reported in males with Xp21 deletion when the deletion extends proximally to include DMD or when larger deletions extend distally to include IL1RAPL1 and DMD.</Attribute>
                <XRef ID="NBK1431" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <XRef ID="777" DB="Orphanet" />
              <XRef ID="C5551510" DB="MedGen" />
              <XRef ID="MONDO:0010256" DB="MONDO" />
              <XRef Type="MIM" ID="300143" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32471" SubmissionDate="2021-08-02" DateLastUpdated="2021-08-07" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300206.0003_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 21" title="IL1RAPL1, EX2-5DEL_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 21" />
        <ClinVarAccession Accession="SCV000032471" DateUpdated="2021-08-07" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 affected males in a family segregating nonspecific X-linked intellectual developmental disorder (XLID21; 300143), Nawara et al. (2008) identified a deletion of exons 2, 3, 4, and 5 in the IL1RAPL1 gene. The deletion was also identified in 3 obligatory female carriers, all of whom were apparently of normal intelligence.</Attribute>
              <Citation>
                <ID Source="PubMed">19012350</ID>
              </Citation>
              <XRef DB="OMIM" ID="300143" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Franek et al. (2011) reported a family in which 3 males had low IQ and other variable features, including hypotonia (2), pectus excavatum (2), prominent jaw (2), synophrys (2), and hyperextensible joints (2). Two had behavioral abnormalities, including impulsivity, oppositional disorder, and hyperactivity. One had pigmentary skin changes. Genetic analysis identified a 635-kb deletion spanning exons 2-5 in the IL1RAPL1 gene, similar to that reported by Nawara et al. (2008), although exact deletion breakpoints were not mapped.</Attribute>
              <Citation>
                <ID Source="PubMed">21484992</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">19012350</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IL1RAPL1" />
          </GeneList>
          <Name>IL1RAPL1, EX2-5DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX2-5DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300206.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 21</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32471" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 21" MappingRef="Preferred">
        <MedGen CUI="C5551510" Name="Intellectual disability, X-linked 21" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

